Sexual dysfunction comprises a group of disorders that cause a distressing reduction in the ability to respond sexually or to experience sexual pleasure. For most cases, doctors have few effective treatments to offer these patients.
Read more ›
S1 Biopharma is evaluating partnerships, collaborations and out-licensing deals that will enable the company to rapidly advance its sexual dysfunction franchise as well as to accelerate the path to commercialization for its drug candidates in the U.S. and internationally.
Read more ›
January 11-14, 2016
San Francisco, California
April 4-6, 2016
Stockholm, Sweden
May 10-11, 2016
Copenhagen, Denmark